Antibiotic-free plasmids
US-9217153-B2 · Dec 22, 2015 · US
US9376700B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9376700-B2 |
| Application number | US-201314406864-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 13, 2013 |
| Priority date | Jun 14, 2012 |
| Publication date | Jun 28, 2016 |
| Grant date | Jun 28, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention includes a selective method of modifying the N-terminus of a protein using an aminoacyl tRNA transferase. In certain embodiments, the method comprises contacting a solution of the protein or peptide with a transferase and a derivative of a molecule, whereby the N-terminus of the protein or peptide is derivatized with the molecule.
Opening claim text (preview).
What is claimed is: 1. A method of derivatizing the N-terminus of a protein or peptide with an amino acid, the method comprising contacting in a solution the protein or peptide with an aminoacyl tRNA transferase (AaT), or a mutant thereof, and an adenosine ester of the amino acid, whereby the N-terminus of the protein or peptide is derivatized with the amino acid. 2. The method of claim 1 , wherein the method is carried out under conditions that do not significantly denature the protein or peptide. 3. The method of claim 1 , wherein the solution is substantially free of a synthetase. 4. The method of claim 3 , wherein the synthetase comprises aminoacyl tRNA synthetase. 5. The method of claim 1 , wherein the amino acid comprises a compound of Formula wherein Xaa is selected from the group consisting of: a salt thereof and any combinations thereof. 6. The method of claim 1 , wherein the amino acid is selected from the group consisting of cysteine, homocysteine, selenocysteine, selenohomocysteine, a derivative thereof and any combinations thereof. 7. The method of claim 1 , wherein the transferase comprises E. coli AaT, V. vulnificus BpT, a mutant thereof and any combinations thereof. 8. The method of claim 1 , wherein the amino acid comprises a detectable label. 9. The method of claim 8 , wherein the detectable label is selected from the group consisting of a radioisotope, stable isotope, fluorophore, electron dense metals, biotin, DNA, RNA, antibody epitope, and any combinations thereof.
attached in position 6, e.g. adenine · CPC title
Mononitriles · CPC title
Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title
not hydrogenated in the hetero ring · CPC title
Labelling of peptides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.